Table 2 Overview included studies including PREFS assessment
Source | Method | Participants | Country | PREFS |
|---|---|---|---|---|
Studies of rheumatoid arthritis treatments | ||||
 1) Alten et al. [21] | Best-Worst scaling | 1588 RA patients | Germany | 3 |
 2) Augustovski et al. [22] | DCE | 240 RA patients | Argentina | 3 |
DCE | 358 patients with RA | Sweden | 4 | |
Conjoint analysis | 136 RA patients | USA | 4 | |
 5) DÃaz-Torné et al. [27] | DCE | 137 RA patients | Spain | 3 |
 6) Fraenkel et al. [28] | Conjoint analysis | 120 RA patients | USA | 3 |
 7) Fraenkel et al. [29] | Conjoint analysis | 156 RA patients | USA | 3 |
 8) Fraenkel et al. [30] | Conjoint analysis | 1273 RA patients | USA & Puerto Rico | 4 |
DCE | 152 Early RA patients | Canada | 5 | |
 10) Ho et al. [33] | DCE | RA patients | Australia | 4 |
 11) Husni et al. [34] | DCE | 510 RA Patients | USA | 4 |
 12) Louder et al. [35] | Conjoint analysis | 380 RA patients | USA | 5 |
 13) Nolla et al. [36] | Conjoint analysis | 165 RA patients | Spain | 3 |
 14) Ozdemir et al. [37] | DCE | 463 RA patients (233 Cheap-talk and 230 Control) | USA | 3 |
 15) Poulos et al. [38] | Conjoint Analysis | 836 RA patients | USA | 5 |
 16) Scalone et al. [39] | DCE | 174 RA patients | Italy | 3 |
 17) Skjoldborg et al. [40] | DCE | 178 RA patients (145 survey 2; 130 survey 3) | Denmark | 4 |
 18) van Heuckelum et al. [41] | DCE | 325 RA patients | The Netherlands | 4 |
 19) Bansback et al. [42] | DCE | 2663 General population asked to imagine they have RA | Canada | 4 |
 20) Harrison et al. [43] | DCE | 733 General population asked to imagine they have RA | Canada | 4 |
Studies of RA prevention | ||||
 21) Finckh et al. [44] | Best worst scaling | 32 FDRs | Switzerland | 4 |
 22) Harrison et al. [45] | DCE | 288 FDRs | USA | 4 |
 23) Harrison et al. [46] | DCE | 30 FDRs 78 RA patients | Canada | 4 |